197 related articles for article (PubMed ID: 29908941)
1. The prognostic value of preoperative neutrophil-to-lymphocyte ratio in patients with upper tract urothelial carcinoma.
Tan P; Xu H; Liu L; Ai J; Xu H; Jiang Y; Zhang X; Yang L; Wei Q
Clin Chim Acta; 2018 Oct; 485():26-32. PubMed ID: 29908941
[TBL] [Abstract][Full Text] [Related]
2. Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy.
Vartolomei MD; Mathieu R; Margulis V; Karam JA; Rouprêt M; Lucca I; Mbeutcha A; Seitz C; Karakiewicz PI; Fajkovic H; Wood CG; Weizer AZ; Raman JD; Rioux-Leclercq N; Haitel A; Bensalah K; Rink M; Briganti A; Xylinas E; Shariat SF
World J Urol; 2017 Jan; 35(1):121-130. PubMed ID: 27209168
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of prognosis using the neutrophil-lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma.
Sung HH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
BJU Int; 2015 Apr; 115(4):587-94. PubMed ID: 24947340
[TBL] [Abstract][Full Text] [Related]
4. The neutrophil-to-lymphocyte ratio as a predictor of intravesical recurrence in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
Kishimoto N; Takao T; Kuribayashi S; Yamamichi G; Nakano K; Kawamura M; Tsutahara K; Tanigawa G; Yamaguchi S
Int J Clin Oncol; 2017 Feb; 22(1):153-158. PubMed ID: 27614622
[TBL] [Abstract][Full Text] [Related]
5. A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomy.
Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Shirotake S; Miyazaki Y; Kobayashi H; Kaneko G; Hagiwara M; Ide H; Obata J; Hoshino K; Hayakawa N; Kosaka T; Hara S; Oyama M; Momma T; Nakajima Y; Jinzaki M; Oya M
Ann Surg Oncol; 2014 Nov; 21(12):4041-8. PubMed ID: 24912614
[TBL] [Abstract][Full Text] [Related]
6. Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients.
Vartolomei MD; Kimura S; Ferro M; Vartolomei L; Foerster B; Abufaraj M; Shariat SF
World J Urol; 2018 Jul; 36(7):1019-1029. PubMed ID: 29468284
[TBL] [Abstract][Full Text] [Related]
7. Effect of hypertension on preoperative neutrophil-lymphocyte ratio evaluation of prognosis of renal cell carcinoma.
Sun J; Ning H; Sun J; Qu X
Urol Oncol; 2016 May; 34(5):239.e9-15. PubMed ID: 26803433
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of preoperative lymphocyte-to-monocyte ratio for patients with upper tract urothelial carcinoma.
Li T; Xu H; Yang L; Tan P; Wei Q
Clin Chim Acta; 2019 May; 492():50-56. PubMed ID: 30763574
[TBL] [Abstract][Full Text] [Related]
9. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
[TBL] [Abstract][Full Text] [Related]
10. Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.
Dalpiaz O; Ehrlich GC; Mannweiler S; Hernández JM; Gerger A; Stojakovic T; Pummer K; Zigeuner R; Pichler M; Hutterer GC
BJU Int; 2014 Sep; 114(3):334-9. PubMed ID: 24053693
[TBL] [Abstract][Full Text] [Related]
11. Validation of the Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor in a Large Cohort of Chinese Patients with Upper Tract Urothelial Carcinoma.
Cao ZP; Guan B; Zhao GZ; Fang D; Xiong GY; Li XS; Zhou LQ
Chin Med J (Engl); 2017 Sep; 130(17):2063-2068. PubMed ID: 28836549
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Role of Neutrophil-to-lymphocyte Ratio-based Markers During Pre- and Postadjuvant Chemotherapy in Patients With Advanced Urothelial Carcinoma of Upper Urinary Tract.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Clin Genitourin Cancer; 2017 Aug; 15(4):e633-e643. PubMed ID: 28174011
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis.
Shao Y; Li W; Wang D; Wu B
World J Surg Oncol; 2020 Oct; 18(1):273. PubMed ID: 33097052
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
Viers BR; Boorjian SA; Frank I; Tarrell RF; Thapa P; Karnes RJ; Thompson RH; Tollefson MK
Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414
[TBL] [Abstract][Full Text] [Related]
15. What is the Role of the Preoperative Blood-Based Inflammation Biomarkers in the Prognosis of Upper Tract Urothelial Carcinoma With Radical Nephroureterectomy? A Single-Centre Retrospective Study.
Luo Z; Jiao B; Huang T; Zhao H; Zhang G
Technol Cancer Res Treat; 2022; 21():15330338221095667. PubMed ID: 35585719
[No Abstract] [Full Text] [Related]
16. Subclassification of upper urinary tract urothelial carcinoma by the neutrophil-to-lymphocyte ratio (NLR) improves prediction of oncological outcome.
Luo HL; Chen YT; Chuang YC; Cheng YT; Lee WC; Kang CH; Chiang PH
BJU Int; 2014 May; 113(5b):E144-9. PubMed ID: 24274691
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of preoperative systemic inflammation markers in localized upper tract urothelial cell carcinoma: a large, multicenter cohort analysis.
Son S; Hwang EC; Jung SI; Kwon DD; Choi SH; Kwon TG; Noh JH; Kim MK; Seo IY; Kim CS; Kang SG; Cheon J; Ha HK; Jeong CW; Ku JH; Kwak C; Kim HH
Minerva Urol Nefrol; 2018 Jun; 70(3):300-309. PubMed ID: 29381018
[TBL] [Abstract][Full Text] [Related]
18. Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma.
Krabbe LM; Bagrodia A; Lotan Y; Gayed BA; Darwish OM; Youssef RF; John G; Harrow B; Jacobs C; Gaitonde M; Sagalowsky AI; Shariat SF; Kapur P; Margulis V
J Urol; 2014 Jan; 191(1):28-34. PubMed ID: 23871758
[TBL] [Abstract][Full Text] [Related]
19. Degree of hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tract.
Chung PH; Krabbe LM; Darwish OM; Westerman ME; Bagrodia A; Gayed BA; Haddad AQ; Kapur P; Sagalowsky AI; Lotan Y; Margulis V
Urol Oncol; 2014 Oct; 32(7):981-8. PubMed ID: 25022858
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma.
Tanaka N; Kikuchi E; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakamura S; Oya M
BJU Int; 2013 May; 111(6):857-64. PubMed ID: 22757942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
